C07K 7/16
Oxytocins
Official title: Oxytocins; Vasopressins; Related peptides
C07K7/16 (Oxytocins) appears on 152 US grants and 94 published applications in this corpus.
Search patents in C07K- Granted patents
- 152
- Published applications
- 94
- Assignees
- 77
- Inventors
- 312
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 0 | 0 |
| 1983 | 7 | 0 |
| 1984 | 7 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 10 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 2 |
| 2003 | 3 | 0 |
| 2004 | 1 | 4 |
| 2005 | 1 | 0 |
| 2006 | 1 | 4 |
| 2007 | 3 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 2 | 6 |
| 2012 | 3 | 4 |
| 2013 | 1 | 3 |
| 2014 | 5 | 5 |
| 2015 | 4 | 6 |
| 2016 | 1 | 1 |
| 2017 | 3 | 6 |
| 2018 | 6 | 4 |
| 2019 | 0 | 6 |
| 2020 | 3 | 5 |
| 2021 | 4 | 3 |
| 2022 | 1 | 5 |
| 2023 | 1 | 7 |
| 2024 | 2 | 6 |
| 2025 | 8 | 2 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oxytocin purifying method and measuring method and kit16 Jun 2026US 12,656,354 B2Fujifilm Wako Pure Chemical Corporation
- Oxytocin analogues and methods for using the same9 Jun 2026US 12,649,765 B2Arizona Board of Regents on Behalf of the University of Arizona
- Desmopressin oral compositions17 Mar 2026US 12,576,125 B2Tulex Pharmaceuticals Inc.
- Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein13 Jan 2026US 12,522,642 B2
- Manufacture of disulfide bonded peptides11 Nov 2025US 12,466,851 B2Bachem Holding AG
- Desmopressin oral compositions13 Aug 2026US 2026/0232754 A1Tulex Pharmaceuticals Inc.
- Use of avpr1a agonists23 Jul 2026US 2026/0207702 A1Kyoto University
- Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure21 May 2026US 2026/0137790 A1Ferring B. V.
- Highly stable oxytocin derivatives30 Apr 2026US 2026/0116922 A1Universitaet Wien
- V1A Receptor Partial Agonist and Method of Use15 Jan 2026US 2026/0015389 A1PharmalN Corporation
Most cited
By later US patents
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier238US 4,801,575 AThe Regents of the University of California · 1989
- Chimeric peptides for neuropeptide delivery through the blood-brain barrier215US 4,902,505 AAlkermes, Inc. · 1990
- Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device156US 8,764,733 B2Rani Therapeutics, LLC · 2014
- Conformationally restricted biologically active peptides, methods for their production and uses thereof89US 5,364,851 AInternational Synthecon, LLC · 1994
- Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device81US 9,205,127 B2Rani Therapeutics, LLC · 2015